If the meningioma has been cured or the disease is well controlled and there are no other uncomfortable symptoms, it is usually possible to receive the new crown vaccine. However, if the patient is undergoing treatment or has an acute exacerbation of the disease, it is generally not recommended to receive the New Crown vaccine. If patients with meningioma have been cured after receiving regular treatment, or their condition is well controlled and relatively stable, and there are no contraindications such as fever, allergy, etc., they are generally allowed to receive New Crown Vaccine. If patients with meningioma have undergone surgical treatment but are still undergoing radiation therapy, it is generally recommended to hold off on the new crown vaccine. If a patient with meningioma is in the acute seizure stage of the disease, experiencing severe seizures, hearing loss, arm or leg weakness and other uncomfortable symptoms, it is also generally not recommended to inject the New Crown vaccine, so as not to affect the recovery of the disease. Whether or not a patient with meningioma can receive the New Crown vaccine depends on a number of factors, and it is recommended that you consult with your primary care physician and vaccinator to avoid adverse consequences.